Taiwan / United States
Every company in the roster headquartered in Taiwan / United States.
Every company in the roster headquartered in Taiwan / United States.
2 of 2 companies
| Company | Pipeline | Most advanced | Next readout | Market cap | Cash & inv. | Runway | R&D / yr |
|---|---|---|---|---|---|---|---|
APRINOIA TherapeuticsPrivate | 1 asset: 1 Ph 1 | APNmAb005Phase 1 · Alzheimer's DiseaseWeak signal | None on record | — | — | — | — |
Elixiron ImmunotherapeuticsPrivate | 1 asset: 1 Ph 2 | EnrupatinibPhase 2 · Alzheimer's Disease | Aug 2027Enrupatinib · Phase 1 | — | — | — | — |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov). Cash shows its balance-sheet month; runway shows a month only when it comes from an earlier report.